Minerva Neuroscience

Minerva Neurosciences, Inc. is a clinical-stage biopharmaceutical company focused on developing a portfolio of product candidates to treat central nervous system (CNS) diseases. Our goal is to transform patient lives by improving therapeutic options. Leveraging deep domain expertise, we have identified and acquired a pipeline of proprietary compounds at various stages of development, which we believe have innovative mechanisms of action. Our executive management team includes globally recognized experts in CNS disorders, addressing significant unmet medical needs.